PubMed چکیده/رکورد

Global burden of type 2 diabetes attributable to dietary risks in working-age adults aged 25-64 years: insights from the GBD 2023 study.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

OBJECTIVE: To estimate the global burden of type 2 diabetes mellitus (T2DM) attributable to dietary risks among working-age adults from 1990 to 2023, stratified by sex, age, region, and Socio-Demographic Index (SDI). Because Global Burden of Disease (GBD) 2023 data are not disaggregated for ages 15-24, analyses were restricted to adults aged 25-64 years, the core working-age group. STUDY DESIGN: GBD 2023 data from 204 countries and territories were analyzed. Age-standardized mortality (ASMR) and disability-adjusted life-year rates (ASDR) attributable to seven dietary risks were estimated using population-attributable fractions and joinpoint regression. RESULTS: During 1990-2023, global ASMR rose from 17.1 to 21.5 per 100,000 (average annual percentage change [AAPC] 0.69%), accelerating after 2010, and ASDR rose from 695.9 to over 800 per 100,000 (AAPC 0.50%). Sugar-sweetened beverages and processed meat were the fastest-growing risks; the low-fiber burden declined slightly. Males bore higher and faster-growing burdens. Pacific Island nations had the highest rates; Eastern Europe and the Middle East grew fastest. Crude DALYs rose most among 25-29-year-olds, largely reflecting demographic change. CONCLUSION: Diet-related T2DM burden is rising among working-age adults, with sugar-sweetened beverages and processed meats growing fastest. Targeted interventions are urgently needed in high-burden regions, particularly for males and younger adults.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Dietary RisksEpidemiological TrendsGlobal Burden of Disease Study 2023 (GBD 2023)Type 2 Diabetes MellitusWorking-Age Population (25–64 Years)
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and enviro…

PubMed2026

Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021.

Viral hepatitis constitutes a primary cause of liver cirrhosis and carcinoma and ranks as the second leading cause of mortality worldwide due to challenges in early detection and limited preventive measures, thereby posing a significant threat to public health. This study analyses the burden and risk factors associated with viral hepatitis at global, regional, and national levels from 1990 to 2021, and projects the disease burden from …

PubMed2026

Temporal trend analysis of the global prevalence of vision impairment and blindness attributable to diabetes from 1990 to 2021.

BACKGROUND: This study aimed to systematically assess the burden and temporal patterns of vision impairment due to diabetes mellitus (DM), including moderate vision loss (MVL), severe vision loss (SVL), and blindness, and to identify the demographic drivers of future changes. METHODS: An age-period-cohort (APC) model was used to evaluate the effects of age, period, and birth cohort on diabetes-related vision impairment, with analyses s…

PubMed2026

Antimicrobial resistance and social inequity: Why the one health approach must centre poverty.

Antimicrobial resistance (AMR) is one of the most consequential threats to global public health. In 2021, bacterial AMR was associated with an estimated 4.71 million deaths globally, including 1.14 million directly attributable to resistance. Yet, despite its designation as a global emergency, policy responses remain heavily focused on surveillance, antimicrobial stewardship, diagnostics, and pharmaceutical innovation. These interventi…